Summary
This prediction ended on 14.12.22 with a price of €0.82. The BUY prediction by krebskrebs for Englobal performed very badly with a performance of -39.49%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Englobal | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by krebskrebs for this prediction
In the thread Englobal diskutieren
Buy mit Kursziel 2,5
In the thread Trading Englobal
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

